Sydow, K. v.; Lieb, R.; Pfister, H.; Höfler, M.; Wittchen, H.: What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug and Alcohol Dependence 68 (1), pp. 49 - 64 (2002)

Uhr, M.; Holsboer, F.; Müller, M.: Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P- glycoproteins. Journal of Neuroendocrinology 14 (9), pp. 753 - 759 (2002)

Wichniak, A.; Geisler, P.; Popp, R.; Brunner, H.; Friess, E.; Zulley, J.: Self-rating of sleepiness with Epworth sleepiness scale and objective assessment of sleepiness with multiple sleep latency test and vigilance task. Pharmacopsychiatry 35 (5), p. XVII - XVII (2002)

Winkelmann, J.; Müller-Myhsok, B.; Wittchen, H.; Hock, B.; Prager, M.; Pfister, H.; Ströhle, A.; Eisensehr, I.; Dichgans, M.; Gasser, T. et al.; Trenkwalder, C.: Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Annals of Neurology 52 (3), pp. 297 - 302 (2002)

Winkelmann, J.; Stautner, A.; Samtleben, W.; Trenkwalder, C.: Long-term course of restless legs syndrome in dialysis patients after kidney transplantation. Movement Disorders 17 (5), pp. 1072 - 1076 (2002)

Zhang, Z.; Lutz, B.: Cre recombinase-mediated inversion using lox66 and lox71: method to introduce conditional point mutations into the CREB- binding protein. Nucleic Acids Research 30 (17), e90, pp. e90 (2002)

Zimmermann, U.; Steffin, B.; Spring, K.; O''Connor, S.; Holsboer, F.: Neuroendocrine aspects of acute tolerance to ethanol. Pharmacopsychiatry 35 (5), pp. XIV - XV (2002)

Fischer, A.; von Rosenstiel, P.; Fuchs, E.; Goula, D.; Almeida, O.; Czeh, B.: The prototypic mineralocorticoid receptor agonist aldosterone influences neurogenesis in the dentate gyrus of the adrenalectomized rat. Brain Research 947 (2), pp. 290 - 293 (2002)

Barkow, K.; Heun, R.; Üstün, T.; Gänsicke, M.; Wittchen, H.; Maier, W.: Test-retest reliability of self-reported age at onset of selected psychiatric diagnoses in general health care. Acta Psychiatrica Scandinavica 106 (2), pp. 117 - 125 (2002)

Bschor, T.; Berghöfer, A.; Ströhle, A.; Kunz, D.; Adli, M.; Müller-Oerlinghausen, B.; Bauer, M.: How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression. Journal of Clinical Psychopharmacology 22 (4), pp. 427 - 430 (2002)

Kalischewski, P.; Kraner, S.; Reuter, M.; Köhler, W.; Steinlein, O.; Sieb, J.: Kongenitales Myasthenie-Syndrom bei einer 18-jährigen Kroatin durch Homozygotie für die 1267delG-Mutation im Gen für die ε -Untereinheit des Azetylcholinrezeptors. Aktuelle Neurologie 29 (6), pp. 298 - 300 (2002)

Kane, L.; Mollenauer, M.; Xu, Z.; Turck, C.; Weiss, A.: Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappa B-dependent transcription. Molecular and Cellular Biology 22 (16), pp. 5962 - 5974 (2002)

Kellner, M.; Yassouridis, A.; Hua, Y.; Wendrich, M.; Naber, D.; Wiedemann, K.: Trait dissociation affects the behavioral response to cholecystokinin tetrapeptide in healthy man. Psychiatry Research 111 (1), pp. 93 - 96 (2002)

Marsicano, G.; Wotjak, C.; Azad, S.; Bisogno, T.; Rammes, G.; Cascio, M.; Hermann, H.; Tang, J.; Hofmann, C.; Zieglgänsberger, W. et al.; Di Marzo, V.; Lutz, B.: The endogenous cannabinoid system controls extinction of aversive memories. Nature 418 (6897), pp. 530 - 534 (2002)

van Gaalen, M.; Reul, J.; Gesing, A.; Stenzel-Poore, M.; Holsboer, F.; Steckler, T.: Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a5-HT1A receptor challenge. Genes Brain and Behavior 1 (3), pp. 174 - 177 (2002)

Wotjak, C.; Ludwig, M.; Ebner, K.; Russell, J.; Singewald, N.; Landgraf, R.; Engelmann, M.: Vasopressin from hypothalamic magnocellular neurons has opposite actions at the adenohypophysis and in the supraoptic nucleus on ACTH secretion. European Journal of Neuroscience 16 (3), pp. 477 - 485 (2002)

Behl, C.; Moosmann, B.: Antioxidant neuroprotection in Alzheimer''s disease as preventive and therapeutic approach. Free Radical Biology and Medicine 33 (2), pp. 182 - 191 (2002)

Ackl, N.; Sonntag, A.; Ising, M.; Auer, D.: Proton magnetic resonance spectroscopy (1H-MRS) as a marker of disease progression in mild cognitive impairment. Neurobiology of Aging 23 (1 Suppl. 1), p. S471 - S471 (2002)

Goodenough, S.; Schaefer, M.; Behl, C.: Role of glycogen synthase kinase 3-beta in the pathology of Alzheimer' s disease. Neurobiology of Aging 23 (1 Suppl. 1), p. S15 - S15 (2002)

Held, K.; Antonijevic, I.; Künzel, H.; Uhr, M.; Wetter, T.; Golly, I.; Steiger, A.; Murck, H.: Oral Mg2+ supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry 35 (4), pp. 135 - 143 (2002)